Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Titan Pharmaceuticals Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +1 vs. Q1 2024
- Shares held
- 32.2K
- +72 (+0.2%) vs. Q1 2024
- Total value
- $179.3K
- −$50.7K (−22.0%) vs. Q1 2024
- New holders
- 1
- 2 more added
- Sold out
- 0
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $69 |
| Q1 2026 | 6 | $130 |
| Q4 2025 | 4 | $154 |
| Q3 2025 | 18 | $107.1K |
| Q2 2025 | 20 | $158.3K |
| Q1 2025 | 17 | $51.9K |
| Q4 2024 | 15 | $9.41K |
| Q3 2024 | 16 | $88.5K |
| Q2 2024 | 18 | $179.3K |
| Q1 2024 | 17 | $230.0K |
| Q4 2023 | 24 | $408.2K |
| Q3 2023 | 27 | $497.8K |
| Q2 2023 | 25 | $632.7K |
| Q1 2023 | 22 | $787.4K |
| Q4 2022 | 23 | $757.9K |
| Q3 2022 | 21 | $1.14M |
| Q2 2022 | 24 | $371.0K |
| Q1 2022 | 24 | $1.24M |
| Q4 2021 | 24 | $430.0K |
| Q3 2021 | 22 | $722.0K |
| Q2 2021 | 23 | $1.51M |
| Q1 2021 | 24 | $988.1K |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Titan Pharmaceuticals Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 1 | $5 | 0.00% | +1 | New |
| Wells Fargo & Company | 1 | $6 | 0.00% | −4−80.0% | Reduced |
| Nemes Rush Group LLC | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 1 | $6 | 0.00% | 00.0% | Unchanged |
| St Germain D J Co Inc | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 1 | $6 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $6 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Cape Investment Advisory, Inc. | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Ransom Advisory, Ltd | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Global Wealth Strategies & Associates | 2 | $11 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3 | $17 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10 | $54 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 12 | $66 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 17 | $95 | 0.00% | +5+41.7% | Added |
| MCF Advisors LLC | 165 | $920 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 717 | $3.99K | 0.00% | +70+10.8% | Added |
| Truist Financial Corp | 31,255 | $174.1K | 0.00% | 00.0% | Unchanged |